Client situation: A major pharma rare disease team required cross-functional alignment on competitor strategy and patient targeting to de-risk and optimise an upcoming launch in a competitive autoimmune disease market.

Eradigm’s approach:

• Ran a 2-day virtual wargame for a 16-person cross-functional US and EU team
• Aligned the group on key competitors and target patient segments
• Anticipated competitor moves and defined response tactics for each scenario
• Optimised launch positioning and identified the highest-impact actions

What the client achieved:

• Significantly improved team understanding of the competitive landscape across patient segments
• Identified key tactics to support superior market positioning against anticipated competitor moves
• Recommended tailored strategic plays to maximise product performance at launch

Client voice: “The way you set up the discussions forced us to challenge ourselves, and the way you not only captured the essence of the conversations but became active members of the discussion was tremendous.” — CI Lead, Rare Diseases, major immunology company